Endosomal proteases in antigen presentation.

Processing of cytoplasmic and endocytized foreign antigens were once thought to be completely separate pathways of peptide generation for MHC class I and class II peptide display. However, recent studies show actually that there is extensive overlap owing, in part, to the positioning of endosomal proteases at sites in which MHC class I and class II paths cross. The questions of how antigens access and persist at sites of endosomal processing are proving to be as important as those regarding the proteases themselves. However, individual proteases within the set of endosomal enzymes have emerged both as targets for microbial evasion from MHC-class-II-dependent immunity and as required elements in autoimmunity. Repeated implication of cathepsins in processing medically important antigens holds promise for therapeutic manipulation of proteases in diseases in which there is disordered adaptive immunity.

[1]  H. Chapman,et al.  Cathepsin S is not crucial to TSHR processing and presentation in a murine model of Graves' disease , 2005, Immunology.

[2]  A. Rudensky,et al.  Cathepsin S Controls MHC Class II-Mediated Antigen Presentation by Epithelial Cells In Vivo1 , 2005, The Journal of Immunology.

[3]  D. Pechkovsky,et al.  Mycobacterium bovis BCG Attenuates Surface Expression of Mature Class II Molecules through IL-10-Dependent Inhibition of Cathepsin S1 , 2005, The Journal of Immunology.

[4]  P. Christadoss,et al.  Cathepsin S Is Required for Murine Autoimmune Myasthenia Gravis Pathogenesis1 , 2005, The Journal of Immunology.

[5]  Z. Cohn,et al.  THE IN VITRO DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES , 1965, The Journal of experimental medicine.

[6]  Delu Zhou,et al.  Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. , 2005, Immunity.

[7]  K. Rock,et al.  Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. , 2004, Immunity.

[8]  Jacques Neefjes,et al.  A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. , 2004, Immunity.

[9]  C. Watts.  The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules , 2004, Nature Immunology.

[10]  D. Turk,et al.  Lysosomal cysteine proteases: facts and opportunities , 2001, The EMBO journal.

[11]  H. Rammensee,et al.  Autophagy promotes MHC class II presentation of peptides from intracellular source proteins , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Goldberg,et al.  Post-proteasomal antigen processing for major histocompatibility complex class I presentation , 2004, Nature Immunology.

[13]  N. Katunuma,et al.  Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. , 1998, Journal of immunology.

[14]  Christoph Peters,et al.  Cathepsin L Regulates CD4+ T Cell Selection Independently of Its Effect on Invariant Chain , 2002, The Journal of experimental medicine.

[15]  Alan J. Barrett,et al.  An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation , 1998, Nature.

[16]  J. Vilček,et al.  Biological functions of IFN-gamma and IFN-alpha/beta: lessons from studies in gene knockout mice. , 1994, [Hokkaido igaku zasshi] The Hokkaido journal of medical science.

[17]  H. Chapman,et al.  Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. , 1998, Biochemistry.

[18]  R. Maehr,et al.  Cathepsin L is essential for onset of autoimmune diabetes in NOD mice. , 2005, The Journal of clinical investigation.

[19]  S. Kaufmann,et al.  Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin. , 2005, The Journal of clinical investigation.

[20]  H. Geuze,et al.  Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump , 1995, The Journal of cell biology.

[21]  H. Ploegh,et al.  Role for Cathepsin F in Invariant Chain Processing and Major Histocompatibility Complex Class II Peptide Loading by Macrophages , 2000, The Journal of experimental medicine.

[22]  C. Harding,et al.  Prolonged Toll-Like Receptor Signaling by Mycobacterium tuberculosis and Its 19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Induced Regulation of Selected Genes in Macrophages , 2004, Infection and Immunity.

[23]  A. Rudensky,et al.  Differential Regulation of Cathepsin S and Cathepsin L in Interferon γ–treated Macrophages , 2003, Journal of Experimental Medicine.

[24]  J. Davoust,et al.  ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells , 2003, Nature.

[25]  A. Rudensky,et al.  A Role for Cathepsin L and Cathepsin S in Peptide Generation for MHC Class II Presentation1 , 2002, The Journal of Immunology.

[26]  Hidde L. Ploegh,et al.  Analysis of Protease Activity in Live Antigen-presenting Cells Shows Regulation of the Phagosomal Proteolytic Contents During Dendritic Cell Activation , 2002, The Journal of experimental medicine.

[27]  H. Ploegh,et al.  Specific role for cathepsin S in the generation of antigenic peptides in vivo , 2002, European journal of immunology.

[28]  A. Rudensky,et al.  Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. , 1998, Science.

[29]  P. Benaroch,et al.  Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone. , 2003, Immunity.

[30]  S. Szabo,et al.  Molecular mechanisms regulating Th1 immune responses. , 2003, Annual review of immunology.

[31]  N. Viner,et al.  Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP , 2002, Nature Immunology.

[32]  A. Rudensky,et al.  Lysosomal cysteine proteases regulate antigen presentation , 2003, Nature Reviews Immunology.

[33]  A. Rudensky,et al.  Thymocyte expression of cathepsin L is essential for NKT cell development , 2002, Nature Immunology.

[34]  H. Ploegh,et al.  Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. , 1996, Immunity.

[35]  H. Ploegh,et al.  Cytokines Regulate Proteolysis in Major Histocompatibility Complex Class II–Dependent Antigen Presentation by Dendritic Cells , 2001, The Journal of experimental medicine.

[36]  H. Ploegh,et al.  Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization , 2004, Nature Immunology.

[37]  H. Chapman,et al.  Cathepsins and compartmentalization in antigen presentation. , 2000, Current opinion in immunology.

[38]  T. Tuschl,et al.  Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy , 2005, Science.

[39]  Alfred Nordheim,et al.  Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S‐independent manner , 2004, Journal of leukocyte biology.

[40]  J. Jenkins,et al.  Structural, Biological, and Evolutionary Relationships of Plant Food Allergens Sensitizing via the Gastrointestinal Tract , 2004, Critical reviews in food science and nutrition.

[41]  L. Tang,et al.  Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection. , 2004, Microbes and infection.

[42]  M. Allez,et al.  Accessory cell function of airway epithelial cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[43]  R. Maehr,et al.  Asparagine Endopeptidase Is Not Essential for Class II MHC Antigen Presentation but Is Required for Processing of Cathepsin L in Mice1 , 2005, The Journal of Immunology.

[44]  Henry C. Chang,et al.  Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen Fate , 2005, Science.

[45]  R. Locksley,et al.  Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. , 2001, Immunity.

[46]  E. Weber,et al.  Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  N. Ishimaru,et al.  Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. , 2002, The Journal of clinical investigation.

[48]  I. Mellman,et al.  Activation of Lysosomal Function During Dendritic Cell Maturation , 2003, Science.

[49]  J. Flynn,et al.  Immune evasion by Mycobacterium tuberculosis: living with the enemy. , 2003, Current opinion in immunology.

[50]  H. Ploegh,et al.  Individual cathepsins degrade immune complexes internalized by antigen‐presenting cells via Fcγ receptors , 2001, European journal of immunology.

[51]  A. Rudensky,et al.  Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. , 1999, Immunity.

[52]  E. Jaffee,et al.  Major histocompatibility complex class II‐restricted presentation of a cytosolic antigen by autophagy , 2003, European journal of immunology.

[53]  H. Nakanishi,et al.  Cathepsin D Deficiency Induces Lysosomal Storage with Ceroid Lipofuscin in Mouse CNS Neurons , 2000, The Journal of Neuroscience.

[54]  H. Ploegh,et al.  The p41 isoform of invariant chain is a chaperone for cathepsin L , 2001, The EMBO journal.

[55]  S. Stevanović,et al.  Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. , 2003, The Journal of clinical investigation.

[56]  S. Fortune,et al.  Mycobacterium tuberculosis Inhibits Macrophage Responses to IFN-γ through Myeloid Differentiation Factor 88-Dependent and -Independent Mechanisms1 , 2004, The Journal of Immunology.